Are you Dr. Quevedo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 27 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
UCSF Osher Center 1545 Divisadero
4TH floor
San Francisco, CA 94115Phone+1 415-353-7700Fax+1 415-353-7358
Summary
- Dr. Sylvestre Quevedo, MD is a board certified internist in San Francisco, California. He is currently licensed to practice medicine in California, North Carolina, and Arizona. He is affiliated with UCSF Medical Center.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Nephrology, 1985 - 1989
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Nephrology, 1983 - 1985
- University of Arizona College of Medicine-TucsonInternship, Transitional Year, 1975 - 1976
- Harvard Medical SchoolClass of 1975
Certifications & Licensure
- AZ State Medical License 1980 - Present
- CA State Medical License 1980 - 2026
- NC State Medical License 2007 - 2009
- CO State Medical License 1976 - 1983
- WA State Medical License 1980 - 1983
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 380 citationsMDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 studyJennifer M. Mitchell, Michael P. Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman
Nature Medicine. 2021-05-10 - 62 citationsMDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.Jennifer M Mitchell, Marcela Ot'alora G, Bessel van der Kolk, Scott Shannon, Michael Bogenschutz
Nature Medicine. 2023-10-01 - 12 citationsMDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.Jennifer M Mitchell, Michael Bogenschutz, Alia Lilienstein, Charlotte Harrison, Sarah Kleiman
Focus. 2023-07-01